Atossa Therapeutics Priced, Nasdaq: ATOS
Develops diagnostic tests and treatments for breast cancer.
Industry: Health Care
First Day Return: -4.0%
Industry: Health Care
ATOS
Develops diagnostic tests and treatments for breast cancer.
| IPO Data | |
|---|---|
| IPO File Date | 02/14/2012 |
| Offer Price | $5.00 |
| Price Range $4.00 - $6.00 | |
| Offer Shares (mm) | 0.8 |
| Deal Size ($mm) | $4 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 11/07/2012 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $4 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Seattle, WA, United States |
| Founded | 2009 |
| Employees at IPO | 10 |
| Website www.atossagenetics.com | |
IPO News for Atossa Therapeutics
Atossa Therapeutics (ATOS) Performance
